longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

AUTL

AUTL
1.8804.08%( -0.080 )

LongbridgeAI

Autolus Therapeutics Q2 2026 earnings preview

MSN
Aug 10, 2026 at 03:13 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Autolus Therapeutics (AUTL) will report Q2 2026 earnings on August 11th. Consensus estimates project an EPS of -$0.19 and revenue of $40.15M, reflecting a 92.1% year-over-year increase. Historically, the company has beaten EPS estimates 50% of the time and revenue estimates 25% of the time over the past year.

Autolus Therapeutics (AUTL) is scheduled to announce Q2 earnings results on Tuesday, August 11th, before market open. The consensus EPS Estimate is -$0.19 (-5.6% Y/Y) and the consensus Revenue Estimate is $40.15M (+92.1% Y/Y). Over the last 1 year, AUTL has beaten EPS estimates 50% of the time and has beaten revenue estimates 25% of the time. Over ...

Login to unlock353characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Autolus Therapeutics

Autolus Therapeutics

AUTL.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--